The best vision therapy software for optometrists (2026) — and my honest admissions as a competitor

Disclosure: I founded VOR Eye Rehab, which appears on this list — in the middle, not the top, and that placement is deliberate. The honest reality: for a classic optometric vision therapy practice, the incumbent ecosystem is still the best fit, and I'd rather say so plainly than win a ranking with a lie. Where we win is the acquired-injury caseload — concussion, TBI, vestibular — that increasingly walks into both optometry and neuro-rehab clinics.

TL;DR

Best full-practice VT platform

Binovi

Best classic home VT program

HTS

Best for amblyopia programs

CureSee

Best for concussion/acquired caseloads

VOR Eye Rehab

For pediatric/developmental VT practices, Binovi remains the most complete practice platform and HTS the dependable per-patient home program — that's the honest top of this list. CureSee covers amblyopia-specific work. VOR Eye Rehab wins the acquired caseload — post-concussion and vestibular patients whose eye exercises need symptom gating and come attached to VOR and habituation programs.

The picks at a glance

Platform Best for Price Protocol depth
Binovi Full VT practices (COVD workflow) Quote; stations historically ≈$3,000+ Deepest VT activity library (anti-suppression, vergence, perceptual)
HTS Home VT programs (CI, vergence) ≈$425–$599 per patient program The classic computerized home protocol lineage
CureSee Amblyopia home therapy Per-patient subscriptions (quote) AI-adjusted amblyopia games
VOR Eye Rehab Concussion/TBI/vestibular oculomotor USD 49/month, 2 active patients included, then USD 9.95/additional active patient/month Saccade/pursuit/convergence/OKN with symptom gating
MedBridge Adjacent PT practices ≈$329/yr per seat General HEP, no VT protocols

What optometrists should demand from VT software

A working vision therapy practice runs on protocol depth: anti-suppression and vergence activities with real perceptive power, home programs patients aged seven can actually run, progress data that maps to VT conventions, and a workflow that fits how in-office sessions happen — patient at a station, therapist orchestrating, doctor reviewing. That accumulated discipline knowledge is why the incumbent ecosystem persists: decades of protocol refinement don't port to general software by adding eye videos to an exercise library.

The newer demand is different: acquired caseloads. Concussion and TBI patients need convergence and saccade work that stops when dizziness spikes and resumes when it clears — symptom-budgeted progression classic VT software never needed to build, because developmental patients don't flare. Practices serving both populations keep discovering that one platform serves each half poorly.

How we ranked (against our own interest)

Binovi tops this list because for its target buyer — the established VT practice — it genuinely is the most complete answer: practice management, in-office activities, home therapy, telehealth, and an activity library deepened by Eyecarrot's acquisition of computer-aided vision therapy assets. Its weaknesses (opaque pricing, station costs) are real but don't displace it for that buyer.

HTS second for value: the classic home program at a transparent per-patient price with a research lineage in convergence insufficiency. CureSee third for amblyopia-specific work. Our platform enters fourth — top of the list only when the caseload is acquired rather than developmental, which is precisely the segment where classic VT tools are weakest. The ranking is caseload-dependent; pretending otherwise would serve no one's patients.

1. Binovi

Best for
Established pediatric/developmental VT practices
Price
≈$3,000+ per station + practice subscription (quote)
VT protocol depth
The full-practice VT ecosystem

The category incumbent and, for the classic VT practice, still the right answer. Binovi Pro runs the practice, Binovi Touch runs in-office activity stations, Connect handles remote delivery, and the activity library — anti-suppression, vergence, tracking, perceptual — carries decades of VT protocol heritage. The Eyecarrot acquisition of CAVT software deepened it further.

The costs of that maturity: quote-based pricing that makes comparison shopping tedious, hardware stations that multiply per treatment room (historically $3,000+ each), and a symptom model that assumes the stable developmental patient — fine for its core audience, thin for fresh concussions. For that core audience, though: buy it, budget it, done.

Visit Binovi

2. HTS (Home Therapy System)

Best for
The home program core at a transparent price
Price
≈$425–$599 per patient program
VT protocol depth
Decades of home VT protocol with research lineage

HTS remains the dependable answer to "computerized home vision therapy without a platform commitment": vergence facility, jump ductions, accommodative rock, prescribed per patient, monitored from the practice, at roughly $425–$599 per patient program through the Bernell ecosystem. Its convergence insufficiency research pedigree is real, and generations of VT practices have run on it.

It's per-patient software, not a practice platform — no in-office station story, no practice dashboards — and nothing about it addresses acquired/symptomatic caseloads. As the home-program workhorse inside a VT practice, it's the best value in the category; as a modernization strategy, it's a component, not the plan.

Visit HTS (Home Therapy System)

3. CureSee

Best for
Amblyopia-dominant pediatric programs
Price
Per-patient subscriptions (quote)
VT protocol depth
Narrow problem, focused AI solution

CureSee does one thing — amblyopia home therapy as adaptive games, monitored remotely by the prescribing clinic — and the focus shows: engagement mechanics built for children, per-patient subscription pricing instead of practice infrastructure, and AI-driven difficulty adjustment within its scope. For practices whose pediatric caseload skews amblyopic, it's a sharp little instrument.

The narrowness cuts both ways: no general VT protocols, no practice management layer, no acquired-injury applicability. It earns a slot when "vision therapy software" really means "amblyopia program delivery" — a legitimate and common meaning inside optometry.

4. VOR Eye Rehab (mine)

Best for
Acquired caseloads: concussion, TBI, vestibular with oculomotor involvement
Price
USD 49/month, 2 active patients included, then USD 9.95/additional active patient/month · patient app free
VT protocol depth
Symptom-gated eye exercises inside a vestibular program

Our honest slot: the acquired-injury side. Saccade, pursuit, convergence, and optokinetic training run inside a symptom-gated engine — five metrics captured around every session, difficulty auto-regressing when dizziness spikes and advancing when it clears — alongside instrumented VOR x1/x2 and real-world video habituation. Projector mode handles wide-field in-clinic stimuli; DHI/ABC/VVAS and AI reports document in medical language.

What we don't have, and your developmental patients need: anti-suppression, vergence-facility and perceptual protocols, VT station workflow, COVD-ecosystem fit. If those words describe your practice, the entries above are your list; we're the referral destination your post-concussion patients increasingly deserve. The two platforms coexisting in one clinic is not a failure state — it's specialization.

Apply for the 30-Day Clinic Pilot

5. MedBridge

Best for
Optometry-adjacent PT partnerships and general programming
Price
≈$329/yr per seat (HEP) · CE plans from ≈$299/yr
VT protocol depth
The general platform your PT partners run

The pragmatic fifth slot: many "vision therapy software" searches come from clinics building broader neuro-rehab offerings with PT partners, and knowing MedBridge — the platform those partners most likely run — matters for co-management. Its concussion and vestibular education catalog is also a genuinely efficient way for an optometry team to build neuro-rehab literacy.

As a VT purchase it's a mismatch: video HEP, no VT protocols, no instrumentation. Include it in your vocabulary for partnerships, not on your workstation.

Visit MedBridge

My pick

Classic VT practice: Binovi if the quote fits your rooms, HTS carrying the home programs if it doesn't — that combination has served the discipline for years and still does. Amblyopia-heavy practice: add CureSee. That's the honest top of this list, competitor or not.

Concussion, TBI, and vestibular caseload with eye-movement involvement: VOR Eye Rehab — symptom-gated progression is the difference between eye exercises a post-concussion brain tolerates and ones it punishes you for. The growing pattern in neuro-focused clinics is both platforms, split by caseload, and that's not indecision — it's the correct reading of two genuinely different disciplines sharing one visual system.

What I'd do today

  1. 1 Split your caseload: developmental/pediatric versus acquired/concussion. The split picks the software; nothing else on this page matters as much.
  2. 2 If you evaluate Binovi, price the full room count — stations multiply — and get the subscription terms in writing alongside the hardware quote.
  3. 3 For acquired patients, run the regression test on any candidate: provoked symptoms in session — does difficulty actually step down automatically?
  4. 4 Consider the split-platform pattern deliberately rather than forcing one tool across both caseloads; the workflow cost of two tools is usually smaller than the clinical cost of one compromise.

Questions

What software do vision therapy practices use?
The established stack: Binovi as the full-practice platform (management, in-office activities, home therapy), HTS for per-patient computerized home programs, and Bernell-ecosystem hardware around them. Newer entries include CureSee for amblyopia-specific home therapy and, for acquired/concussion caseloads, VOR Eye Rehab's symptom-gated oculomotor platform. Choice tracks caseload composition more than feature lists.
Can vision therapy software handle post-concussion patients?
Mostly no — and that's a design assumption, not an oversight. Classic VT platforms assume a symptom-stable patient doing progressively harder perceptual work; post-concussion patients flare. Symptom-gated platforms (VOR Eye Rehab) track the concussion symptom cluster around every session and titrate difficulty automatically, which is the architecture acquired caseloads require. Some practices run classic VT software for developmental patients and a symptom-gated platform for acquired ones.
How much does vision therapy software cost?
Across the field: HTS at roughly $425–$599 per patient program; CureSee per-patient subscriptions by quote; Binovi quote-based with stations historically around $3,000+ each plus practice subscriptions; VOR Eye Rehab at USD 49/month, 2 active patients included, then USD 9.95/additional active patient/month with a free patient app; MedBridge around $329/yr per seat. Total cost depends almost entirely on patient volume and room count — model your own practice rather than comparing stickers.
Is computerized home vision therapy effective?
For its studied indications, yes — home-based computerized vergence/accommodative programs (the HTS lineage) have randomized-trial support in convergence insufficiency, and structured home programs are standard care. Effectiveness tracks adherence and correct progression, which is what software contributes. For amblyopia, game-based approaches show meaningful outcomes in their trials. None of that transfers automatically to acquired injury — where the gating of difficulty against symptoms, not the activities themselves, is the active ingredient.

Run your next vestibular caseload on VOR Eye Rehab

Purpose-built VOR and oculomotor training, five-metric symptom tracking, AI progression, projector mode, and an RTM billing dashboard. Professional: USD 49/month, 2 active patients included, then USD 9.95/additional active patient/month. Patient app free. 30-day founder-guided pilot.

Promotional platform fee before December 31, 2026; standard fee: USD 89/month. The patient app is free.

Apply for the Clinic Pilot

Pricing checked against public sources in October 2026. Binovi and CureSee are quote-based; HTS pricing varies by reseller. Verify current terms with vendors.